• Analysis of factor VIII levels in haemophilia A treated patients – preliminary results of pharmacokinetic studyPikta, Marika; Kaju, Kaspar; Malikov, A.; Urbala, Maike; Saks, K.; Rahuoja, Kaisa; Varik, M.; Lepik, K.; Ross, MarikenHaemophilia2023 / p. 107 https://doi.org/10.1111/hae.14715
• Assessment of biological response to desmopressin in VWD patients: preliminary resultsMettis, Laura Johanna; Szanto, Timea; Pikta, Marika; Saks, K.Haemophilia2025 / p. 149 https://doi.org/10.1111/hae.15148 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=HAEMOPHILIA&year=2024 https://www.webofscience.com/wos/woscc/full-record/WOS:001508530600283
• Performance evaluation of a one-stage clotting assay in monitoring efanesoctocog alfa activity: Insights from the ECAT 2024 surveyPikta, Marika; Mettis, Laura Johanna; Rea, Anneliis; Titova, TatjanaHaemophilia2026 / art. PP-176 (238) https://onlinelibrary.wiley.com/doi/10.1111/hae.70232
• Preliminary results of the evaluation of pharmacokinetic profiles in Haemophilia A patients receiving Efanesoctocog AlfaPikta, Marika; Mettis, L. J.; Rea, A.; Titova, T.; Arjakse, J.; Siirand, M. S.; Rahuoja, K.; Suursaar, K.; Saks, K.Haemophilia2026 / p. 41 https://doi.org/10.1111/hae.70195